Dengue Virus Serotype-2 Impairs Proliferation of Healthy Donors' T Lymphocytes

被引:5
|
作者
Fuentes-Miranda, C. J. [1 ]
Sanchez-Garcia, F. J. [1 ]
Coker, A. R. [2 ]
Rojas-Espinosa, O. [1 ]
Salinas-Tobon, R. [1 ]
Moreno-Altamirano, M. M. B. [1 ]
机构
[1] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Inmunol, Mexico City 11340, DF, Mexico
[2] UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, London, England
关键词
T lymphocytes; Dengue virus; Cell proliferation; NF-AT; NF-kappa B; Intracellular Ca2+; CYTOKINE PRODUCTION; HEMORRHAGIC-FEVER; INTERFERON-GAMMA; CELL RESPONSES; INFECTION; INTERLEUKIN-2; MACROPHAGES; ACTIVATION; TARGETS; REPLICATION;
D O I
10.1159/000357180
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: T lymphocytes are not infected by dengue virus (DENV), nevertheless it is possible that exposure to DENV may affect their function. T lymphocytes from DENV-infected individuals are impaired in their proliferative capacity, although this effect has been attributed to altered function of antigen-presenting cells rather than to an intrinsic defect on T lymphocytes. Here we analyzed whether T lymphocytes from healthy donors became impaired in their proliferative capacity following in vitro exposure to DENV serotype-2 (DENV-2), as well as the possible mechanisms for this. Methods: Isolated CD4+ and CD8+ T lymphocytes from healthy donors were in vitro exposed to DENV-2, before polyclonal activation, cell proliferation, IL-2 synthesis. IL-2R alpha expression, nuclear translocation of NF-AT and NF-kappa B, and intracellular calcium flux were assessed. Results: In vitro exposure of both CD4+ and CD8+ T lymphocytes from healthy donors to DENV-2 impairs cell proliferation, IL-2 synthesis, and IL-2Ra (CD25) cell membrane expression. Signalling wise, exposure to DENV-2 impairs the nuclear translocation of NF-AT, downstream of intracellular calcium mobilization, as well as that of NF-kappa B. Conclusion: In the course of a dengue infection, direct exposure of T lymphocytes to DENV could affect cell-mediated immune responses. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:83 / 92
页数:10
相关论文
共 50 条
  • [41] Molecular characterization of dengue virus reveals regional diversification of serotype 2 in Colombia
    Laiton-Donato, Katherine
    Alvarez, Diego A.
    Pelaez-Carvajal, Dioselina
    Mercado, Marcela
    Ajami, Nadim J.
    Bosch, Irene
    Usme-Ciro, Jose A.
    VIROLOGY JOURNAL, 2019, 16 (1)
  • [42] A new genetic variant of dengue serotype 2 virus circulating in the Peruvian Amazon
    Falconi-Agapito, Francesca
    Selhorst, Philippe
    Merino, Xiomara
    Torres, Fiorella
    Michiels, Johan
    Fernandez, Connie
    Talledo, Michael
    Arien, Kevin K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 136 - 138
  • [43] Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2
    de la Guardia, Carolina
    Stephens, David E.
    Dang, Hang T.
    Quijada, Mario
    Larionov, Oleg V.
    Lleonart, Ricardo
    MOLECULES, 2018, 23 (03):
  • [44] Vimentin is required for dengue virus serotype 2 infection but microtubules are not necessary for this process
    Wei Chen
    Na Gao
    Jia-li Wang
    Yan-ping Tian
    Zong-tao Chen
    Jing An
    Archives of Virology, 2008, 153 : 1777 - 1781
  • [45] Molecular characterization of dengue virus reveals regional diversification of serotype 2 in Colombia
    Katherine Laiton-Donato
    Diego A. Alvarez
    Dioselina Peláez-Carvajal
    Marcela Mercado
    Nadim J. Ajami
    Irene Bosch
    José A. Usme-Ciro
    Virology Journal, 16
  • [46] Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus
    Yang, Wang
    Yan, Huacheng
    Ma, Yuling
    Yu, Tiantian
    Guo, Hongxia
    Kuang, Yuchan
    Ren, Ruiwen
    Li, Jintao
    IMMUNOBIOLOGY, 2016, 221 (03) : 432 - 439
  • [47] Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
    Zhu, Deanna R.
    Rajesh, Alecia J.
    Meganck, Rita M.
    Young, Ellen F.
    Munt, Jennifer E.
    Tse, Victor L.
    Yount, Boyd
    Conrad, Helen
    White, Laura
    Henein, Sandra
    Desilva, Aravinda M.
    Baric, Ralph S.
    MBIO, 2023, 14 (05):
  • [48] In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2
    Euanorasetr, Jirayut
    Intra, Bungonsiri
    Thunmrongsiri, Nutthanit
    Limthongkul, Jitra
    Ubol, Sukathida
    Anuegoonpipat, Atchareeya
    Kurosu, Takeshi
    Ikuta, Kazuyoshi
    Nihira, Takuya
    Panbangred, Watanalai
    JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, 2019, 65 (04) : 197 - 203
  • [49] The Role of Heterotypic DENV-specific CD8+ T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection
    Talarico, Laura B.
    Batalle, Juan P.
    Byrne, Alana B.
    Brahamian, Jorge M.
    Ferretti, Adrian
    Garcia, Ayelen G.
    Mauri, Aldana
    Simonetto, Carla
    Hijano, Diego R.
    Lawrence, Andrea
    Acosta, Patricio L.
    Caballero, Mauricio T.
    Paredes Rojas, Yesica
    Ibanez, Lorena I.
    Melendi, Guillermina A.
    Rey, Felix A.
    Damonte, Elsa B.
    Harris, Eva
    Polack, Fernando P.
    EBIOMEDICINE, 2017, 20 : 202 - 216
  • [50] Molecular Characterization of Dengue Virus Serotype 2 Cosmospolitan Genotype From 2015 Dengue Outbreak in Yunnan, China
    Jiang, Liming
    Ma, Dehong
    Ye, Chao
    Li, Lihua
    Li, Xiaoman
    Yang, Jiajia
    Zhao, Yujiao
    Xi, Juemin
    Wang, Xiaodan
    Chen, Junying
    Pan, Yue
    Shan, Xiyun
    Sun, Qiangming
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8